While a number of siRNA delivery systems have been developed, the methods used in their preparation are not suitable for large-scale production. We herein report on methodology for the large-scale preparation of liposomal siRNA using a fluidic device and tangential flow filtration. A number of studies have appeared on the use of fluidic devices for preparing and purifying liposomes, but no systematic information regarding appropriate membrane type of commercially available apparatus is available. The findings reported herein indicate that, under optimized conditions, a fluidic device and tangential flow filtration can be used to produce siRNA lipid nanoparticles with the same characteristics as traditional ones'. The in vivo silencing efficiency of these lipid nanoparticles in the liver was comparable to laboratory-produced nanoparticles. In addition, con-focal laser scanning microscopy analyses revealed that they accumulated in the liver accumulation at the same levels as particles produced by batch-type and continuous-type procedures. This methodology has the potential to contribute to the advancement of this process from basic research to clinical studies of liposomal DDS.
Introduction
Since siRNA can inhibit a gene of interest in mammalian cells without severe toxicity, the delivery of siRNA delivery to a target tissue or a cell has been a subject of intense interest [1] [2] [3] . Liposomes are one of the most highly developed carriers for use in this area, since they are highly efficient and are biocompatible [4, 5] . However, it is difficult to prepare liposomes on a large-scale using traditional preparation methods, such as the reverse phase evaporation method, the lipid hydration method, freeze-thawing and extrusion technique [6] . The use of microfluidic devices combined with the ethanol dilution method have been reported to be useful for preparing liposomes. Such methodology includes staggered herringbone structures [7] , microfluidic devices with on-chip micro dialysis [8] , multi-channel fluids [9] , thermoplastic microfluidic devices [10] , an ultra-sound assisted microfludic device [11] for the large-scale preparation of liposomes.
The objective of this study was to develop a simple, robust method for the large-scale preparation of liposomes using commercially available instruments. Liposome formulation generally consists of two procedures namely, a mixing step and a purification step. In the mixing step, an organic solvent containing lipid molecules and a buffer, which may include therapeutics such as an anti-cancer drug or siRNA, are rapidly mixed in a microfluidic device. A sudden decrease in the concentration of the organic solvent results in the formation of liposomes. The rapid mixing produces lipid nano-particles with a homogeneous particle size distribution and is highly reproducible.
Specifically the formulation of size-limited lipid nano-particles requires very rapid mixing within milliseconds [12] . To remove organic solvent in the mixture, lipid nano-particles (LNPs) are then subjected to a removal procedure, such as dialysis, ultrafiltration and ultracentrifugation. As liposomes are composed of hydrophobic molecules, the membrane material used in these operations are thought to be critical.
Lastly, almost all therapeutics must be sterilized by filtration, if they are to be used in clinical procedures. Previous reports indicate that liposomes can be sterilized by gamma irradiation [13, 14] . However, such instrumentation is not commonly available in laboratories, readily available semi-large-scale preparation methods are generally used to achieve further progress in pre-clinical studies dealing with developing liposomal therapeutics.
For the efficient siRNA delivery, we developed an LNP-type siRNA delivery system, a multi-functional envelop-type nano device (MEND), which enables nucleic acids and other macromolecules to be assembled into LNPs [15] . We previously reported w MEND containing a pH-responsive cationic lipid, YSK05, (YSK-MEND) could deliver therapeutic nucleic acids to target tissues, such as liver [16] [17] [18] , cancer [19, 20] and tumor endothelial cells [21] . Using the YSK-MEND as a model carrier, we mixed the lipid and siRNA solution, removed the organic solvent by tangential flow filtration (TFF) and sterilized the final liposome preparation by filtration. We report herein on the effect of flow velocity, flow rate at the mixing step, the type TFF membrane and sterilization by filtration on the characteristics of the YSK-MEND.
Materials and Methods

Materials
YSK05 was synthesized as previously reported [22] . Anti-coagulation-factor 7 siRNA (si-FVII) was purchased from Hokkaido System Science (Sapporo, Japan). si-FVII sequences; sense 5'-gga ucs ucu caa guc uua cTT-3' anti-sense 5'-gua aga cuu gag aug auc cTT-3' (lower cases and upper cases denote RNA and DNA, respectively).
Cholesterol (chol) was purchased from SIGMA Aldrich (St. Louis, MO).
1,2-dimiristoyl-rac-grylerol methoxypolyethylene glycol 2,000 (PEG-DMG), egg phosphatidyl choline (EPC) were purchased from the NOF CORPORATION (Tokyo, Japan). 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) and 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine (DiD) were purchased from PromoKine (Heidelberg, Germany). Phosphate buffered saline without Mg 2+ and Ca
2+
(PBS (-)) was purchased from Wako Pure Chemicals (Osaka, Japan).
Preparation of EPC/chol liposomes
To preliminarily optimize the preparation conditions for LNPs, we first prepared required. The characteristics of the MENDs were determined using a Zetasizer Nano ZS ZEN360. A siRNA encapsulation efficiency and recovery ratio were calculated using RiboGreen, as previously reported [20] .
Animal study
Male, 4-week-old ICR mice were purchased from SLC Japan (Shizuoka, Japan). The experimental protocols were reviewed and approved by the Hokkaido University Animal Care Committee in accordance with the Guide for the Care and Use of Laboratory Animals. 
Observation of the accumulation of MENDs in the liver by con-focal laser scanning microscopy
Livers were removed from ICR mice under ether anesthesia 30 min after the MENDs labeled with DiI were injected into the tail vein. The collect liver tissue was immersed in PBS containing 10 μg/mL of Hoechst33342 (Dojindo, Tokyo, Japan) for 30 min. The liver was observed by Nikon A1 microscopy.
Statistical Analysis
Comparisons between multiple treatments were made using the one way analysis of variance (ANOVA), followed by the Bonferroni or SNK test. Pair-wise comparisons between treatments were made using the student's t-test. A P-value of <0.05 was considered to be significant.
Results and Discussion
Alteration of mixing method for siRNA and lipid solution
Prior to the MEND preparation, EPC and cholesterol liposomes were formulated by microfluidic mixing. At low flow rate (lipid; 0.1 -1.0 mL/min), particle size was very large and the polydispersity index (PdI) of the liposomes indicated a heterogeneous particle size distribution ( Figure 1A) . On the other hand, small liposomes with a homogenous particle distribution could be assembled when a higher flow rate (lipid; 2.0 -4.0 mL/min) was used. When the concentration of lipid was too low (<0.5 mM), it
was not possible to obtain single dispersed liposomes ( Figure 1B) . Accordingly, the flow rate was fixed at 3.0/12.0 (lipid/buffer) mL/min in subsequent experiments.
We also prepared an siRNA-loaded MEND. Based on the above result, the lipid and siRNA flow rate was set to 4.0 and 12.0 mL/min, respectively. Moreover, since very rapid mixing resulted in the formation of smaller particles, the amount of PEG-DMG used was decreased to 1 mol% from 3 mol% for preparing a MEND with the same particle size using the microfluidic device (data not shown 
Purification by tangential flow filtration (TFF)
The alcohol and siRNA that was not encapsulated were removed by the TFF system using a membrane that was composed of polyether sulfone (PS) or polyethersulfone (PES), instead of a spin column. The MEND prepared by manual mixing was subjected to TFF purification, and its physiological properties and siRNA and lipid RR examined ( Table 2 ). In addition, lipid absorption per surface area was calculated from the value in the datasheet for the TFF device. The partitioning coefficient (logP) calculated by ChemBioDraw Ultra software of PS and PES monomer is 7.811 and 1.103, respectively.
The higher hydrophobicity of PS appeared to contribute to the absorption of MENDs.
As a result, mPES was found to be superior to PS in the siRNA and lipid RR. The absorption of lipid to the filter membrane of the TFF system with mPES and the spin column were similar. Likewise, altering the purification method had no effect on silencing effect after the systemic injection of the MEND ( Figure 3A) . PdI; polydispersity index, ZP; zeta potential, EE; encapsulation efficiency, RR; recovery ratio For a more strict comparison, the distribution of MENDs in the liver was evaluated by confocal laser scanning microscopy (CLSM). Fluorescence derived from MENDs were detected throughout the liver in the both the spin column and the TFF system with PES groups (Figure 3B ).
Sterilization of MEND by filtration
To validate the method used to sterilize the MEND, we evaluated four kinds of membranes, polycarbonate (PC), cellulose acetate (CA), cellulose ester (CE) and PES.
After passing the fluorescently labeled MEND through 0.2 μm-pore membranes, the RR value was drastically decreased by the filtration using CE (Figure 4) . On the other hand, 90% of the lipid and siRNA of the MEND were recovered in the case of CA, PC and PES. Thus, all of the materials, except for CE, could be used for sterilization. The exact reason for why only CE failed result in sterilization is not clear. Further study of membrane materials and the shape of the opening in the membrane should be required for the efficent filtration of LNPs.
Serial preparation of MEND using a fluidic device, TFF and filter sterilization.
Finally, we assembled the MEND by a continuous procedure, that is, combining the micromixer, TFF purification and filter sterilization. The MENDs were prepared by a previously described manual method (MEND batch ) or by fluidic mixing, TFF and sterilization (MEND con ) on a one mg siRNA scale and FVII mRNA expression levels were then compared. The silencing efficiency ( Figure 5A ) and liver delivery ( Figure   5B ) of these MENDs were similar. On the other hand, the distribution of MEND batch was a bit more homogenous than that of the MEND con ( Figure 5C ). Taken together we identified the optimized conditions for preparing MENDs, and thus succeeded in preparing siRNA-loaded LNP on a large scale using commercially available devices. 
